Clark Street Value
Monday, September 23, 2024
Aerovate Therapeutics: Broken Biotech, Shell Company? Potential Liquidation
›
I'm a little late posting this one, but as mentioned in the comment section of my Mid-Year update, I did add Aerovate Therapeutics (AVTE...
16 comments:
Wednesday, August 7, 2024
Howard Hughes: PSH Considering a Take-Private Offer
›
Just a brief news post, I'll use the comment section to update my thoughts as this situation develops. Last night, 8/6, Pershing Square...
25 comments:
Wednesday, July 10, 2024
HilleVax: Failed Vaccine Trial, Pre-SA, Trading Below Cash
›
HilleVax (HLVX) (~$85MM market cap) is a clinical-stage biotech that focuses on developing vaccines, their initial focus has been on a vacci...
25 comments:
Sunday, June 30, 2024
Mid Year 2024 Portfolio Review
›
** Note, I'm a little late in posting my mid-year review as I was unplugged a bit for the last couple weeks. Back dating the post to it...
34 comments:
Tuesday, June 11, 2024
Vanda Pharmaceuticals: 2 Bidders, Entrenched Management, Upcoming Business Catalysts
›
Vanda Pharmaceuticals (VNDA) (~$365MM market cap) is a biopharma company with a number of drugs either already being commercialized, on the ...
24 comments:
Wednesday, May 29, 2024
Ikena Oncology: 50% RIF, Trading Below Cash, Strategic Alternatives
›
The broken biotech basket has been emptying out lately, but the latest addition is Ikena Oncology (IKNA) (~$75MM market cap), a clinical sta...
26 comments:
Tuesday, May 28, 2024
Seaport Entertainment: Initial Form 10 Thoughts, Spinoff, Rights Offering
›
The first public draft of the Seaport Form 10-12 came out on Friday, I took a quick read of it, here are some initial thoughts that I'l...
15 comments:
›
Home
View web version